Log In
BCIQ
Print this Print this
 

IONIS-APO(a)-LRx (formerly ISIS-APO(a)-LRx)

  Manage Alerts
Collapse Summary General Information
Company Ionis Pharmaceuticals Inc.
DescriptionLigand conjugated antisense version of ISIS-APO(a)Rx, an antisense oligonucleotide that inhibits apolipoprotein A
Molecular Target
Mechanism of ActionAntisense therapy
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPhase I/II
Standard Indication Cardiovascular (unspecified)
Indication DetailsReduce elevated lipoprotein(a) (LPA) levels
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today